Quantcast

Latest Egenix Inc. Stories

2014-09-16 12:31:53

MILLBROOK, N.Y., Sept. 16, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Stephan Vagner, PhD to its Scientific Advisory Committee. Dr. Vagner, a graduate of the University of Toulouse, France, performed research at Embl (European Molecular Biology Laboratory) Heidelberg, Germany, and at Inserm, the French institute of health and medical research. He is a Research Director at Inserm and works both at the Curie...

2014-06-27 08:26:03

MILLBROOK, N.Y., June 27, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce that Paul H. Schwartz, DVM, CVA has joined Egenix, Inc. to head up a new subsidiary that will focus on veterinary medicine. We are honored to have Dr. Schwartz aboard, and are confident that he will contribute to the further success of Egenix. Dr. Paul Schwartz is a Doctor of Veterinary Medicine with extensive practices throughout New York. He is accomplished in the...

2014-06-04 12:28:49

MILLBROOK, N.Y., June 4, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of William T. Nolan to its Corporate Advisory Committee. Mr. Nolan has been an investment banker for over forty years specializing in corporate finance, turnarounds and securities sales. He began his career at Brown Brothers, Harriman & Company in New York and then held positions at Howard, Weil, Labouisse, Friedrichs & Co., Hill Samuel/Wood,...

2014-05-16 12:27:48

MILLBROOK, N.Y., May 16, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Hans-Guido Wendel, MD, to its Scientific Advisory Committee. Dr. Wendel, a graduate of the University of Aachen, Germany, trained in clinical hemato-oncology in Germany, performed research at Cold Spring Harbor and presently holds a tenure-track position at Sloan Kettering Institute NYC focusing on the genetics of lymphatic cancer and initially...

2014-02-13 12:27:43

MILLBROOK, N.Y., Feb. 13, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Emmanuel Petricoin III, Ph.D. to its Board of Directors and Scientific Advisory Committee. Dr. Emanuel F Petricoin has been the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor. Prior to this position, he served as Co-Director of the FDA-NCI...

2014-02-13 12:27:42

MILLBROOK, N.Y., Feb. 13, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Dendy Young to its Board of Directors. Dendy Young is the Managing Partner of McLean Capital, LLC, a private equity firm, based in McLean, VA, which focuses on investments in government information technology as well as other angel investments. He is a member of Blu Venture Investors, a venture capital investment company that supports early stage...

2014-02-13 12:27:40

MILLBROOK, N.Y., Feb. 13, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Adam J. Stein, Ph.D. to its Scientific Advisory Committee. Dr. Stein has over eighteen years of experience in structural biology, with the last seven in applying structural biology and biophysical chemistry to the drug discovery efforts in biotech. While at deCODE Genetics, he was able to design fragment libraries that enabled us to elucidate...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related